The invention generally relates to intravascular catheters, and more particularly to catheter tips for guiding the catheter through a patient's blood vessels during deployment.
Intravascular devices are devices that are generally placed within the lumen of a blood vessel during a therapeutic procedure. The therapeutic procedure may be any one of a wide variety of procedures, such as for example, stent delivery, angioplasty, atherectomy, embolic filtering, aortic occlusion, or any other therapeutic procedure performed in a blood vessel. The intravascular device used in such procedures typically include a catheter or guidewire for obtaining access to a desired location in a patient's blood vessel.
In general, the therapeutic procedures involve inserting a catheter or guidewire into a blood vessel such as the femoral artery. The catheter is then pushed into the blood vessel and into branches of blood vessels until the distal end of the catheter has reached a desired location within the patient's blood vessels. Once properly positioned, the therapeutic procedure is performed.
The path to the desired location in the patient's blood vessels is typically not an easy one. The blood vessels contain many branches into other blood vessels of varying sizes creating a tortuous path to almost any position in the body. Some applications use imaging to assist in properly placing the catheter. Radio opaque markers on strategic points on the catheter may be used to locate the parts of the catheter on an x-ray or other suitable form of imaging as the catheter is being placed. The use of imaging however requires special equipment often only available in specially equipped rooms in a hospital or other facility. There are intravascular procedures that may need to be performed on an emergency basis outside of a hospital setting. For example, a patient may require an aortic occlusion device to slow blood loss while at an accident site.
Even when a patient is in a hospital setting and requires a therapeutic procedure involving placing a catheter in the patient's blood vessels, it would be desirable to place the catheter without the need to use special imaging equipment. It would be desirable in some therapeutic procedures to have the option to administer a catheter from the patient's bedside without the need to transfer the patient to another room.
Another difficulty with placing a catheter is due to the construction of a typical catheter. Catheters typically extend distally to a tip. In some catheters, a guiding balloon near the tip is used to center the tip as the catheter winds its way through the tortuous path of the patient's blood vessels. Otherwise, the tip is pushed through the blood vessels without any real advantage for navigating the different branches that the catheter could follow.
There is a need in the art for a way to insert a catheter in a patient's blood vessels and to place the catheter at a desired location in the blood vessels without the need for special imaging equipment or for special facilities.
In view of the above, a device is provided for guiding a catheter through a patient's blood vessels. The device comprises a catheter guiding tip extending distally at a distal end of the catheter with an outer dimesion (sometimes referred to herein as “thickness”) substantially the same as an outer dimension of the catheter. The catheter guiding tip has at least one guiding member that expands distally to a tip portion having a shape in an uncompressed state that is larger than the catheter outer dimension along at least one axis perpendicular to a longitudinal axis of the catheter. The catheter guiding tip is deformable for insertion in a sheath larger than the tip portion when the tip portion is compressed but smaller than the tip portion when the tip porion is not compressed and is resilient for resuming the shape in the uncompressed shape when not subject to compression forces.
The methods, systems, and apparatuses are set forth in part in the description which follows, and in part will be obvious from the description, or can be learned by practice of the methods, apparatuses, and systems. The advantages of the methods, apparatuses, and systems will be realized and attained by means of the elements and combinations particularly pointed out in the appended claims. It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of the methods, apparatuses, and systems, as claimed.
In the accompanying figures, like elements are identified by like reference numerals among the several preferred embodiments of the present invention.
The foregoing and other features and advantages of the invention will become more apparent from the following detailed description of exemplary embodiments, read in conjunction with the accompanying drawings. The detailed description and drawings are merely illustrative of the invention rather than limiting, the scope of the invention being defined by the appended claims and equivalents thereof.
While the invention has been described in connection with various embodiments, it will be understood that the invention is capable of further modifications. This application is intended to cover any variations, uses or adaptations of the invention following, in general, the principles of the invention, and including such departures from the present disclosure as, within the known and customary practice within the art to which the invention pertains.
Furthermore, the invention is described in the context of a catheter system. It will be understood that the catheter guiding tips may be used with catheters for a variety of different therapeutic or diagnostic indications involving vascular interventions, including, for example and without limitation, vascular occlusion, angioplasty, stent delivery, artherectomy, drug delivery, imaging or the like. Applications of catheter systems in which embodiments of the invention find advantageous use may utilize any suitable access site, such as, for example, the femoral artery, the brachial artery, the subclavian artery, or any other suitable blood vessel. In addition, applications in which embodiments of the invention find advantageous use may also involve venous as well as arterial blood vessels.
In the following description, when reference is made to the terms “proximal” or “proximally” it is intended to mean a portion or component of the catheter system that is oriented away from the body into which the system is or is intended to be placed. Conversely, when reference is made to the terms “distal” or “distally” it is intended to mean a portion or component of the catheter system that is oriented toward the body into which the system is or is intended to be placed. Thus, for example, the catheter guiding tip described hereinafter is located at a distal end of the catheter system, while the proximal hub is located at a proximal end of the catheter system.
The catheter member 104 may be any suitable wire, tube-like, or rod-like structure that may be fitted with the intravascular device 102 to extend into the patient's blood system, i.e., the patient's blood vessels, to position the intravascular device 102 at a desired location. The catheter member 104 may be made of a bio-compatible metal, such as a suitable metal alloy (e.g. nitinol) or stainless steel, or a bio-compatible polymer. The material of the catheter will typically be dictated by the therapeutic procedure, and on how long the catheter is to remain in the patient's blood vessels. The catheter member 104 may include one or more lumens that may be used, for example, to transport balloon filling fluids, to deliver drugs or other therapeutic materials such as thrombolyic agents, or to communicate with sensors.
The proximal hub 106 may be any suitable device for communicating between the proximal end of the catheter system 100 and the portions of the catheter in the blood vessels. The proximal hub 106 may include for example, ports or fittings (e.g. luer locks) for fluidly communicating with lumens in the catheter. In some examples, the proximal hub 106 may also provide a proximal endpoint or mechanisms (such as markings) for determining the positional extent of the catheter system 100 in the patient's blood vessels.
The catheter guiding tip 108 distally extends from a distal end of the catheter member 104 to a distal tip. The catheter guiding tip 108 extends from the catheter member 104 and expands distally to a tip portion. The tip portion has a shape in an uncompressed state that is larger than the catheter outer dimension along at least one axis perpendicular to a longitudinal axis of the catheter member 104. The catheter guiding tip 108 is deformable for insertion in a sheath during deployment and is resilient for resuming the shape in the uncompressed shape when not subject to compression forces.
The catheter guiding tip 108 may be an extension of the catheter member 104 and made of the same material as the catheter member 104. Alternatively, the catheter guiding tip 104 may be a component that is fixedly attached to a distal end of the catheter member 104. The catheter guiding tip 108 may have a shape and size in an uncompressed state that assists in guiding the catheter through the tortuous paths of the blood vessel. The catheter guiding tip 108 also has a shape that renders the tip atraumatic so as to prevent damage to the blood vessels during deployment.
The catheter member 204 may include a catheter lumen 222 as shown in
The shape of the tip portion 202 of the catheter guiding tip 200 in
In the example shown in
In an example implementation of the tip portion 202 described with reference to
The tip portion 108 (and corresponding parts of the various embodiments) of the catheter systems 100 (and corresponding parts of the various embodiments), have a very soft, atraumatic tip to prevent the tip from perforating or tearing the blood vessel into which inserted as it is advanced through the blood vessel. Catheter shafts, in general, need to be stiffer to offer pushability and prevent buckling. Therefore the tip portion of the catheter system transitions from a relatively stiff shaft section to a very soft tip. The transition can occur in one step or over a series of steps. By way of example and not limitation, one embodiment of the catheter system 200 of the present invention (and corresponding parts of the various embodiments) has a catheter member 204, made of a PEBAX® polymer with a 72 durometer (D) hardness, with a coaxial nitinol hypotube running down the central lumen 222. This catheter member is rather stiff to have good pushability and also withstand aortic occlusion. The nitinol hypotube terminates just distal of any expansible members, such as a balloon that may be carried by the catheter system, but the catheter member still is a PEBAX® polymer with a 72 D hardness. The catheter tip portion 202 is softer, and has a significantly lower hardness, such as 40 D, but may also be made of a PEBAX® polymer to make the tip atraumatic. Some catheter systems transition from high durometers of the catheter member 204 to tip portions 204 having lower durometers over multiple steps (e.g. 72 D, 60 D, 55 D, 40 D, 35 D, etc), usually depending on the rest of the catheter design.
Additionally, it is often helpful to transition from a catheter member 204 made of a PEBAX® polymer as a tubular member with a hardness of 72 D to a solid tip portion 202 made of a PEBAX® polymer with a hardness of 40 D. If the tip portion, even if made of a PEBAX® polymer with a hardness of 40 D were a tube, rather than a solid, it may not function as well, since it may collapse, kink, be too flimsy, etc. However, the hardness of the tip portion can be adjusted to be an atraumatic tip based on the construction of the tip portion, its shape, whether it is tubular or solid, or the like, in view of the description herein.
To prepare for insertion into the patient's vascular system, by means of an introducer sheath, the tip portion 202 may be straightened in a compressed state to ease insertion into the valve of the introducer sheath. Introducer sheaths are commonly used to provide access to blood vessels, such as the femoral artery, and often have a hemostasis valve to minimize blood loss. A peel-away sheath insertion tool can be used to straighten the tip portion 202 into a compressed state to ease insertion of the catheter tip past the introducer sheath valve. A peel-away sheath is often comprised of a plastic tube that can be peeled apart after assisting the insertion of the catheter into the introducer sheath to separate it from the catheter. Once the tip portion 202 exits the introducer sheath, it may automatically re-shape to its shape in an uncompressed or undeformed state as shown in
It is noted that the tip portion 202 of the catheter guiding tip 200 in the examples illustrated in
The bulbous shape 404 of the tip portion 402 may include a space filler 412 in the inner space of the bulbous shape 404. The space filler 412 may be made of foam, porous plastic or any other suitable compressible material and may be formed unitarily with the bulbous shape 404 or separately inserted or attached within the bulbous shape. In an example embodiment, the inner space of the bulbous shape 404 may simply be air.
The foregoing description of implementations has been presented for purposes of illustration and description. It is not exhaustive and does not limit the claimed inventions to the precise form disclosed. Modifications and variations are possible in light of the above description or may be acquired from practicing the invention. The claims and their equivalents define the scope of the invention.
The present application is a national stage application under 35 U.S.C. § 371 of International Patent Application No. PCT/US2015/035061, filed Jun. 10, 2015 and titled, “Conduit Guiding Tip,” which was published under International Publication No. WO 2015/191685 A1 and claims the benefit of U.S. Provisional Patent Application No. 62/010,297, filed on Jun. 10, 2014 titled, “Conduit Guiding Tip,” the disclosures of which are incorporated herein by reference.
This invention was made with government support under Contract No. W81XWH-12-1-0558 awarded by U.S. Army Medical Research Materiel Command. The government has certain rights in the invention.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2015/035061 | 6/10/2015 | WO | 00 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2015/191685 | 12/17/2015 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
2156289 | Hoy | May 1939 | A |
4464172 | Lichtenstein | Aug 1984 | A |
4713888 | Broselow | Dec 1987 | A |
4777951 | Cribier et al. | Oct 1988 | A |
4823469 | Broselow | Apr 1989 | A |
4865549 | Sonsteby | Sep 1989 | A |
4926885 | Hinkle | May 1990 | A |
4983166 | Yamawaki | Jan 1991 | A |
5135494 | Engelson et al. | Aug 1992 | A |
5169386 | Becker et al. | Dec 1992 | A |
5282479 | Havran | Feb 1994 | A |
5320605 | Sahota | Jun 1994 | A |
5383856 | Bersin | Jan 1995 | A |
5447503 | Miller | Sep 1995 | A |
5505702 | Arney | Apr 1996 | A |
5522400 | Williams | Jun 1996 | A |
5571093 | Cruz et al. | Nov 1996 | A |
5718678 | Fleming, III | Feb 1998 | A |
5738652 | Boyd et al. | Apr 1998 | A |
5911702 | Romley et al. | Jun 1999 | A |
6011988 | Lynch et al. | Jan 2000 | A |
6013019 | Fischell et al. | Jan 2000 | A |
6102930 | Simmons, Jr. | Aug 2000 | A |
6113579 | Eidenschink et al. | Sep 2000 | A |
6146370 | Barbut | Nov 2000 | A |
6161547 | Barbut | Dec 2000 | A |
6165199 | Barbut | Dec 2000 | A |
6190356 | Bersin | Feb 2001 | B1 |
6231572 | Hart et al. | May 2001 | B1 |
6248121 | Nobles | Jun 2001 | B1 |
6280434 | Kinoshita | Aug 2001 | B1 |
6423031 | Donlon | Jul 2002 | B1 |
6453572 | Cross et al. | Sep 2002 | B2 |
6575932 | O'Brien et al. | Jun 2003 | B1 |
6579221 | Peterson | Jun 2003 | B1 |
6602270 | Leschinsky et al. | Aug 2003 | B2 |
6656153 | Sakai et al. | Dec 2003 | B1 |
6666814 | Downey et al. | Dec 2003 | B2 |
6669679 | Savage et al. | Dec 2003 | B1 |
6679860 | Stiger | Jan 2004 | B2 |
6695811 | Samson et al. | Feb 2004 | B2 |
6719270 | Ozawa | Apr 2004 | B2 |
6719720 | Voelker et al. | Apr 2004 | B1 |
6733513 | Boyle et al. | May 2004 | B2 |
6735532 | Freed et al. | May 2004 | B2 |
6736790 | Barbut et al. | May 2004 | B2 |
6746462 | Selmon | Jun 2004 | B1 |
6796959 | Davis et al. | Sep 2004 | B2 |
6936056 | Nash et al. | Aug 2005 | B2 |
6979318 | McDonald et al. | Dec 2005 | B1 |
7341571 | Harris et al. | Mar 2008 | B1 |
7434326 | Gifford | Oct 2008 | B2 |
7503904 | Choi | Mar 2009 | B2 |
7503909 | Kusu et al. | Mar 2009 | B2 |
7763043 | Goodin et al. | Jul 2010 | B2 |
7892469 | Lim et al. | Feb 2011 | B2 |
7909810 | Noone | Mar 2011 | B2 |
7951186 | Eidenschink et al. | May 2011 | B2 |
7951819 | Niculescu-Duvaz et al. | May 2011 | B2 |
7959644 | Shriver | Jun 2011 | B2 |
8088103 | Teeslink et al. | Jan 2012 | B2 |
8162879 | Hattangadi et al. | Apr 2012 | B2 |
8241241 | Evans et al. | Aug 2012 | B2 |
8262611 | Teeslink et al. | Sep 2012 | B2 |
8419648 | Corl et al. | Apr 2013 | B2 |
8430899 | Dae et al. | Apr 2013 | B2 |
8499681 | Kanner et al. | Aug 2013 | B2 |
8545382 | Suzuki et al. | Oct 2013 | B2 |
8655798 | Humphrey et al. | Feb 2014 | B2 |
8672868 | Simons | Mar 2014 | B2 |
8747358 | Trombley, III et al. | Jun 2014 | B2 |
8814900 | Fleming, III | Aug 2014 | B2 |
8900214 | Nance et al. | Dec 2014 | B2 |
8948848 | Merhi | Feb 2015 | B2 |
8951565 | McCarthy | Feb 2015 | B2 |
9131874 | Eliason et al. | Sep 2015 | B2 |
D748257 | Franklin | Jan 2016 | S |
9414843 | Pavcnik et al. | Aug 2016 | B2 |
9474882 | Franklin | Oct 2016 | B2 |
9687333 | Angel et al. | Jun 2017 | B2 |
20020193735 | Stiger | Dec 2002 | A1 |
20030032974 | Leschinsky et al. | Feb 2003 | A1 |
20030167038 | Yozu et al. | Sep 2003 | A1 |
20040073162 | Bleam et al. | Apr 2004 | A1 |
20040082935 | Lee et al. | Apr 2004 | A1 |
20040254528 | Adams et al. | Dec 2004 | A1 |
20050059931 | Garrison et al. | Mar 2005 | A1 |
20050148812 | Nigroni et al. | Jul 2005 | A1 |
20050261725 | Crawford et al. | Nov 2005 | A1 |
20070043307 | Raulerson et al. | Feb 2007 | A1 |
20070043409 | Brian et al. | Feb 2007 | A1 |
20070129466 | Kagawa et al. | Jun 2007 | A1 |
20070135830 | Schaeffer | Jun 2007 | A1 |
20070219466 | Tremulis et al. | Sep 2007 | A1 |
20070219488 | Francescatti | Sep 2007 | A1 |
20080027356 | Chen et al. | Jan 2008 | A1 |
20080082046 | Kato et al. | Apr 2008 | A1 |
20080082119 | Vitullo | Apr 2008 | A1 |
20080243067 | Rottenberg et al. | Oct 2008 | A1 |
20080262477 | Djaladat | Oct 2008 | A1 |
20090026595 | Kadoi | Jan 2009 | A1 |
20090062666 | Roteliuk | Mar 2009 | A1 |
20090171272 | Tegg et al. | Jul 2009 | A1 |
20090171293 | Yang et al. | Jul 2009 | A1 |
20090265951 | Black | Oct 2009 | A1 |
20090287079 | Shriver | Nov 2009 | A1 |
20090312807 | Boudreault et al. | Dec 2009 | A1 |
20100016735 | Harpas et al. | Jan 2010 | A1 |
20100041984 | Shapland et al. | Feb 2010 | A1 |
20100234915 | Herlich et al. | Sep 2010 | A1 |
20100262076 | Rowe et al. | Oct 2010 | A1 |
20100268017 | Siess | Oct 2010 | A1 |
20100280451 | Teeslink et al. | Nov 2010 | A1 |
20110196412 | Levit et al. | Aug 2011 | A1 |
20110295301 | Hoem et al. | Dec 2011 | A1 |
20110295302 | Mohl | Dec 2011 | A1 |
20110301630 | Hendriksen et al. | Dec 2011 | A1 |
20120101413 | Beetel et al. | Apr 2012 | A1 |
20120108979 | Franklin et al. | May 2012 | A1 |
20120109057 | Krolik et al. | May 2012 | A1 |
20120116352 | Rangi | May 2012 | A1 |
20120130359 | Turovskiy | May 2012 | A1 |
20120172911 | Welch | Jul 2012 | A1 |
20120215166 | Barki | Aug 2012 | A1 |
20120271231 | Agrawal | Oct 2012 | A1 |
20120302994 | Wilson et al. | Nov 2012 | A1 |
20130102926 | Eliason et al. | Apr 2013 | A1 |
20130102929 | Haight et al. | Apr 2013 | A1 |
20130190619 | Nudel | Jul 2013 | A1 |
20130281869 | Barbut et al. | Oct 2013 | A1 |
20130289607 | Pedersen et al. | Oct 2013 | A1 |
20140221898 | Kurrus et al. | Aug 2014 | A1 |
20140243873 | Franklin | Aug 2014 | A1 |
20140249504 | Franklin et al. | Sep 2014 | A1 |
20140316012 | Freyman et al. | Oct 2014 | A1 |
20140378869 | Sela et al. | Dec 2014 | A1 |
20150012031 | Rago et al. | Jan 2015 | A1 |
20150039012 | Solar et al. | Feb 2015 | A1 |
20150367098 | Aggerholm et al. | Dec 2015 | A1 |
20160000446 | Eliason et al. | Jan 2016 | A1 |
Number | Date | Country |
---|---|---|
1094861 | Apr 2005 | EP |
1658808 | May 2006 | EP |
1911484 | Apr 2008 | EP |
2389974 | Nov 2011 | EP |
2716323 | Apr 2014 | EP |
2297259 | Jul 1996 | GB |
H 03198868 | Aug 1991 | JP |
H 09-164208 | Jun 1997 | JP |
2002505165 | Feb 2002 | JP |
2003535652 | Dec 2003 | JP |
200714820 | Jan 2007 | JP |
2008546471 | Dec 2008 | JP |
2011245300 | Dec 2011 | JP |
9220398 | Nov 1992 | WO |
9713542 | Apr 1997 | WO |
9834670 | Aug 1998 | WO |
199924105 | May 1999 | WO |
9944666 | Sep 1999 | WO |
0197743 | Dec 2001 | WO |
2004049970 | Jun 2004 | WO |
2006135853 | Dec 2006 | WO |
2007001701 | Jan 2007 | WO |
2007022592 | Mar 2007 | WO |
2008013441 | Jan 2008 | WO |
2010070685 | Jun 2010 | WO |
2011133736 | Oct 2011 | WO |
2014003809 | Jan 2014 | WO |
2014134215 | Sep 2014 | WO |
2014152191 | Sep 2014 | WO |
2015006828 | Jan 2015 | WO |
2015035393 | Mar 2015 | WO |
2015191685 | Dec 2015 | WO |
2016149653 | Sep 2016 | WO |
Entry |
---|
Extended European Search Report dated Jun. 26, 2017 in EP Application No. 14842370. |
Int'l Preliminary Report dated Jul. 17, 2017 in Int'l Application No. PCT/US2016/023223. |
Int'l Search Report and Written Opinioin dated Sep. 28, 2017 in Int'l Application No. PCT/US2017/035729. |
Office Action dated Sep. 19, 2017 in JP Application No. 2015-559309. |
Office Action dated Sep. 12, 2017 in JP Application No. 2016-546035. |
Office Action dated Oct. 12, 2017 in CA Application No. 2,980,018. |
Holcomb et al., “Causes of death in US Special Operations Forces in the global war on terrorism: 2001-2004,” Annals of Surgery, vol. 245, No. 6, pp. 986-991 (2007). |
Sohn et al., “Demographics, Treatment, and Early Outcomes in Penetrating Vascular Combat Trauma,” Arch Surg, vol. 143, No. 8, pp. 783-787 (2008). |
White et al., “The Epidemiology of Vascular Injury in the Wars in Iraq and Afghanistan,” Annals of Surgery, vol. 253, No. 6, pp. 1184-1189. |
Fenton et al., “Comparing risks of alternative medical diagnosis using Bayesian arguments,” J. Biomed. Inf., vol. 43, pp. 485-495 (2010). |
Patel et al., “Bayesian Designs for Device Clinical Trials,” MDG Forum, Waltham, MA., Nov. 3, 2010, downloaded from web page: <http://www.cytel.com/pdfs/Patel_Bayes_Devices_Slides_11.18.10.pdf>. |
Guidance for the Use of Bayesian Statistics in Medical Device Clinical Trials, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health, Division of Biostatistics, Office of Surveillance and Biometrics, Feb. 5, 2010. |
Int'l Preliminary Report on Patentability dated Sep. 11, 2015 in Int'l Application No. PCT/US2014/018779. |
Int'l Search Report and Written Opinion dated Jun. 8, 2014 in Int'l Application No. PCT/US2014/018779. |
Int'l Search Report and Written Opinion dated Oct. 14, 2011 in Int'l Application No. PCT/US2011/033368. |
Sandgren et al., “The Diameter of the Common Femoral Artery in Healthy Human: Influence of Sex, Age, and Body Size,” Journal of Vascular Surgery, vol. 29, No. 3, pp. 503-510 (1999). |
Sam II et al., “Blunt Traumatic Aortic Transection: Endoluminal Repair with Commercially Available Aortic Cuffs,” Journal of Vascular Surgery, vol. 38, No. 5, pp. 1132-1135 (2003). |
Peterson et al., “Percutaneous endovascular repair of blunt thoracic aortic transection,” Journal of Trauma, vol. 59, No. 5, pp. 1062-1065 (2005). |
Office Action dated Oct. 28, 2014 in U.S. Appl. No. 13/642,465. |
Office Action dated Apr. 6, 2015 in U.S. Appl. No. 13/642,465. |
Stannard et al., “Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) as an Adjunct for Hemorrhagic Shock,” J. Trauma, vol. 71, pp. 1869-1872 (2011). |
Ledgerwood et al., “The Role of Thoracic Aortic Occlusion for Massive Hemoperitoneum,” J Trauma, vol. 16, No. 8, pp. 610-615 (1976). |
Detrano et al. “Bayesian Probability Analysis: a Prospective Demonstration of its Clinical Utility in Diagnosing Coronary Disease,” Circulation, vol. 69, No. 3, pp. 541-547 (1984). |
Int'l Search Report and Written Opinion dated Jan. 28, 2015 in Int'l Application No. PCT/US2014/054802. |
Int'l Preliminary Report on Patentability dated Mar. 24, 2016 in Int'l Application No. PCT/US2014/054802. |
Int'l Preliminary Report on Patentability dated Nov. 1, 2012 in Int'l Application No. PCT/US2011/033368. |
Langewouters et al., “The static elastic properties of 45 human thoracic and 20 abdominal aortas in vitra and the parameters of a new model,” Journal of Biometrics, vol. 17, No. 6, pp. 425-435 (1984). |
Hughes, “Use of an Intra-Aortic Balloon Catheter Tamponade for Controlling Intra-Abdominal Hemorrhage in Man,” Surgery, vol. 36, pp. 65-68 (1954). |
Office Action dated Aug. 23, 2016 in AU Application No. 2015274743. |
Extended European Search Report dated Oct. 5, 2016 in Europe Application No. EP 14 75 6640. |
Supplemental Search Report dated Dec. 19, 2016 in EP Application No. 15806534. |
Int'l Preliminary Report dated Dec. 22, 2016 in Int'l Application No. PCT/US2015/035061. |
Int'l Search Report and Written Opinion dated Sep. 4, 2015 in Int'l Application No. PCT/US2014/035061. |
Extended Search Report dated Mar. 24, 2017 in EP Application No. 14842370. |
Int'l Search Report and Written Opinion dated Apr. 21, 2017 in Int'l Application No. PCT/US2016/023223. |
Extended Search Report dated Mar. 21, 2017 in EP Application No. 15806534. |
Office Action dated Apr. 11, 2017 in JP Application No. 2016-546035. |
Office Action dated Mar. 20, 2017 in CA Application No. 2,797,237. |
Chen et al., “The Renal Length Nomogram: A Multivariable Approach,” The Journal of Urology, vol. 168, pp. 2149-2152 (Nov. 2002). |
Number | Date | Country | |
---|---|---|---|
20170043123 A1 | Feb 2017 | US |
Number | Date | Country | |
---|---|---|---|
62010297 | Jun 2014 | US |